These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma. Newman EN, Jones RL, Hawkins DS. Pediatr Blood Cancer; 2013 Jul; 60(7):1113-7. PubMed ID: 23192939 [Abstract] [Full Text] [Related]
6. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY. Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [Abstract] [Full Text] [Related]
7. 18F-FDG PET-CT versus MRI for detection of skeletal metastasis in Ewing sarcoma. Bosma SE, Vriens D, Gelderblom H, van de Sande MAJ, Dijkstra PDS, Bloem JL. Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339 [Abstract] [Full Text] [Related]
8. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed? Ulaner GA, Magnan H, Healey JH, Weber WA, Meyers PA. AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717 [Abstract] [Full Text] [Related]
9. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18. Basu D, Siegel BA, McDonald DJ, Nussenbaum B. Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620 [Abstract] [Full Text] [Related]
10. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma. Raciborska A, Bilska K, Drabko K, Michalak E, Chaber R, Pogorzała M, Połczyńska K, Sobol G, Wieczorek M, Muszyńska-Rosłan K, Rychlowska-Pruszyńska M, Rodriguez-Galindo C, Dziuk M. Clin Transl Oncol; 2016 Feb; 18(2):189-95. PubMed ID: 26250765 [Abstract] [Full Text] [Related]
12. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Graafland NM, Leijte JA, Valdés Olmos RA, Hoefnagel CA, Teertstra HJ, Horenblas S. Eur Urol; 2009 Aug; 56(2):339-45. PubMed ID: 19477581 [Abstract] [Full Text] [Related]
13. Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma. Ruggiero A, Lanni V, Librizzi A, Maurizi P, Attinà G, Mastrangelo S, Giordano A, Riccardi R. J Pediatr Hematol Oncol; 2018 May; 40(4):277-284. PubMed ID: 29620679 [Abstract] [Full Text] [Related]
14. Different 18 F-FDG PET parameters for the prediction of histological response to neoadjuvant chemotherapy in pediatric Ewing sarcoma family of tumors. El-Hennawy G, Moustafa H, Omar W, Elkinaai N, Kamel A, Zaki I, Farid N, El-Kholy E. Pediatr Blood Cancer; 2020 Nov; 67(11):e28605. PubMed ID: 32706520 [Abstract] [Full Text] [Related]
15. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ. J Clin Oncol; 2009 Oct 01; 27(28):4774-80. PubMed ID: 19720925 [Abstract] [Full Text] [Related]
16. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging. Liu FY, Yen TC, Chen MY, Lai CH, Chang TC, Chou HH, Hong JH, Chen YR, Ng KK. Cancer; 2009 Dec 01; 115(23):5470-80. PubMed ID: 19739235 [Abstract] [Full Text] [Related]
17. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site. Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G. Q J Nucl Med Mol Imaging; 2006 Mar 01; 50(1):15-22. PubMed ID: 16557200 [Abstract] [Full Text] [Related]
18. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. Iagaru A, Mittra E, Yaghoubi SS, Dick DW, Quon A, Goris ML, Gambhir SS. J Nucl Med; 2009 Apr 01; 50(4):501-5. PubMed ID: 19289439 [Abstract] [Full Text] [Related]
19. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma. Kim SY, Kim JS, Yi JS, Lee JH, Choi SH, Nam SY, Cho KJ, Lee SW, Kim SB, Roh JL. Ann Surg Oncol; 2011 Sep 01; 18(9):2579-84. PubMed ID: 21409485 [Abstract] [Full Text] [Related]
20. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging]. Cai L, Gao S, Li DC, Li YS, Chen QS, Xing XL. Zhonghua Zhong Liu Za Zhi; 2009 Feb 01; 31(2):134-8. PubMed ID: 19538892 [Abstract] [Full Text] [Related] Page: [Next] [New Search]